
Markets don’t move in straight lines. Some weeks it is interest rates spooking investors. Other weeks it is AI disruption, geopolitics, or earnings season surprises. But while headlines change constantly, the characteristics that drive long-term wealth creation rarely do.
If I were putting fresh money to work today, these are three ASX shares I’d feel comfortable buying and holding through the volatility.
Goodman Group (ASX: GMG)
The first ASX share I would buy is Goodman Group. It sits at the heart of logistics, ecommerce, and data infrastructure, developing and owning industrial properties in key infill locations across major global cities.
While property can be cyclical, Goodman’s strategy focuses on high-demand sites that are difficult to replicate. That scarcity supports long-term value creation.
Importantly, the group has been expanding its exposure to data centres, an area benefiting from structural growth in cloud computing and artificial intelligence. That gives Goodman a foot in both physical logistics and digital infrastructure, which bodes well for its earnings growth in the coming years.
ResMed Inc. (ASX: RMD)
Another ASX share I would buy is ResMed. ResMed operates in sleep apnoea and respiratory care, which are two areas supported by long-term demographic trends. Ageing populations, rising obesity rates, and greater awareness of sleep disorders are driving demand and look set to continue doing so for a long time to come.
In fact, the company estimates that it has a total addressable market in excess of 1 billion people. This gives it a significant growth runway over the next decade and beyond.
In addition, ResMed has evolved beyond hardware. Its growing software ecosystem connects patients, healthcare providers, and insurers, creating recurring revenue and deeper customer relationships.
TechnologyOne Ltd (ASX: TNE)
A final ASX share I’d consider is TechnologyOne. It provides software to governments, universities, and large enterprises. The good thing about these customers is that they rarely switch providers lightly, which has historically created strong retention and recurring revenue.
In addition, the company’s shift to a full SaaS model has improved visibility and margins, while its expansion into the UK has opened up a meaningful new growth avenue. So much so that management believes TechnologyOne is positioned to double in size every five years.
If it delivers on this, then its shares could deliver strong returns for investors over the next decade, especially after significant share price weakness recently.
The post 3 ASX shares I’d buy and hold through market volatility appeared first on The Motley Fool Australia.
Should you invest $1,000 in Goodman Group right now?
Before you buy Goodman Group shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Goodman Group wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 Jan 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Here are the top 10 ASX 200 shares today
- 3 ways to play the ASX tech share sell-off
- 2 ASX tech stocks smashed to multi-year lows
- 3 blue-chip ASX 200 shares I would buy and hold
- The $10,000 Test: Which ASX shares would I still own after 10 years?
Motley Fool contributor James Mickleboro has positions in Goodman Group, ResMed, and Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group, ResMed, and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Goodman Group and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.